1. Nakahara H, Noguchi S, Murakami N, Hoshi H, Jinnouchi S, Nagamachi S, et al. Technetium-99m-sestamibi scintigraphy compared with thallium-201 in evaluation of thyroid tumors.J Nucl Med 1996; 37: 901–904.
2. Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study).J Nucl Med 1992; 33: 1801–1807.
3. Yamamoto Y, Nishiyama Y, Satoh K, Takashima H, Ohkawa M, Fujita J, et al. Comparative study of technetium-99m-sestamibi and thallium-201 SPECT in predicting chemotherapeutic response in small cell lung cancer.J Nucl Med 1998; 39: 1626–1629.
4. Maublant J, de Latour M, Mestas D, Clemenson A, Charrier S, Feillel V, et al. Technetium-99m-sestamibi uptake in breast tumor and associated lymph nodes.J Nucl Med 1996; 37: 922–925.
5. Caner B, Kitapcl M, Unlu M, Erbengi G, Calikoglu T, Gogus T, et al. Technetium-99m-MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99m-MDP.J Nucl Med 1992; 33: 319–324.